The quantitative determination of calcium in urine is important in those conditions associated with hypocalcaemia, hypercalcaemia and in patients with renal calculi. The Sulkowitch test is of value in the qualitative assessment of increased calcium excretion in urine but there is no alternative test to assess decreased excretion. The classical methods for the determination of calcium in urine are long and tedious and hardly suitable for the clinical laboratory.
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The following method, using Nuclear Fast Red, has been found to be satisfactory for such a purpose and has the advantage that a large number of urines can be examined quickly and with little labour.
Neutral Fast Red appears to have been introduced by McGee-Russell (1955) as a histochemical test for calcium.
Procedure
The examinations are usually carried out on twenty-four hour collections of urine. 10 ml. of ION hydrochloric acid are added to each litre of urine to ensure that the phosphates and oxalate remain in solution.
This quantity of acid was found not to affect the intensity of the colour produced both in unknowns and standards. Reagents 1. Stock standard solution of calcium (1 mg. Ca/ml.), This is prepared from calcium carbonate.
2. Working standard solutions of calcium. These are prepared from the stock solution and correspond to 5,10 and 20 mg. Ca/IOOml.
Nuclear Fast Red reagent.
This is prepared fresh just before use. 20 ml. of a stock solution of the dye are diluted to 100 ml. with O·IN sodium hydroxide (preferably stored in a plastic bottle).
A commercial solution of the dye (Clinton) is used but a 0·1 % solution of Nuclear Fast
Red (British Drug Houses Ltd.) has been found to be satisfactory.
Technique Urine, undiluted and diluted with an equal volume of water, is used. 6 ml. quantities of Nuclear Fast Red reagent are measured into a series of test tubes which are then placed in a water bath (20°-25°) for 15 minutes.
0·2 ml. of urine (diluted or undiluted) or of standard solution is then added. The contents of the tubes are mixed and then placed in the water bath for a further 5 minutes. A blank prepared from 0·2 ml. of water is also included.
At the end of this time, readings are made against the blank at 575 mu, A Unicam Spectrophotometer S.P.600 was used in these experiments.
Standards. The relationship between concentration and optical density is not linear hence it is necessary to set up a number of standards, e.g. 5, 10 and 20 mg. Call 00 mi.
Magnesium. Magnesium does appear to have a slight effect. This appears to be related to the quantity of sodium hydroxide incorporated in the Nuclear Fast Red reagent.
In the present method, the intensity of colour due to magnesium appears to be about 15-20 % 
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of that due to the corresponding concentration of calcium. This is negligible in most cases.
A correction can however be applied if necessary. Standards of magnesium (5 and 10 mg.Mg.j100 ml.) may be set up and the magnesium content of the urine determined by the Titan Yellow method (Neill and Neely, 1956) .
A comparison has been made of the calcium content of urine as determined by the Nuclear Fast Red method and as determined by a standard method ' (Shohl and Pedley, 1922) . The results are shown in Table I. A forty-five year old woman with idiopathic hypoparathyroidism was described. She had a thirteen-year history of laryngeal stridor. For six months she had complained of general malaise and paraesthesiae. She had had three epileptic fits in a month.
In addition to hyperphosphataemia, 8·3 mg.j 100 mI., and hypocalcaemia 4·8 mg./lOO mI., she was found to have hypokalaemia 2·3 m.eq/litre. The E.C.G. was typical of both hypocalcaemia and hypokalaemia. The E.E.G. was diffusely abnormal with bursts of slow waves.
Daily serum calcium and potassium estimations were made during the subsequent eight weeks and a remarkable, statistically very highly significant, parallel relationship was noted between them. It was suggested that a protective mechanism exists, bringing about hypokalaemia in severe hypocalcaemia states. This would prevent or lessen the adverse effects of hypocalcaemia on nerves and muscle, particularly heart muscle, because of the antagonistic effect of calcium and potassium ions. In spite of the initial hypokalaemia and a total daily potassium loss of approximately 18 milliequivalents, an oral potassium supplement (90 m.eq daily) was immediately excreted in the urine, the daily loss rising to 130 milliequivalents.
A renal mechanism for the production of hypokalaemia in severe hypocalcaemia was postulated.
The arterial pH was determined at frequent intervals by the Astrup micro method. The expected association between alkalosis and hypokalaemia was seen. An arterial pH of 7·59 was found with a serum calcium of 4·6 mg./IOO ml. Thus the alkalosis of hypokalaemia might act against the suggested protective effect.
The serum calcium rose significantly (6,2 mg.j 100 ml.) with intra-muscular parathormone but failed to respond to Calciferol 600,000 units orally daily for three weeks and also to a low phosphate diet with Aludrox to precipitate phosphate in the gut and Probenecid to increase its renal excretion.
